Skip to main content
Smart Investors Daily
HA

OTC · HALB

Halberd Corporation

Healthcare · Biotechnology

$0.00

Up+$0.00 (+0.00%)

Updated Aug 23, 2026, 4:35 AM

SID Score

4.2/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
688.69K
P/E ratio
-42.29
Dividend yield
0.00%
52-week range
— – —
Volume
226.97K
Avg. volume
1.73M

Price performance

HALB price history

1M range · 0 trading sessions · Daily adjusted prices

HALB does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest HALB news

The latest Smart Investors Daily articles mentioning HALB.

HALB research

Overview

Company profile and research snapshot.

Company profile

HALBERD CORP

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

prismmediawire.com · Nov 3, 2025

Halberd Corporation Continues Seeking Government Contracts with Scientists at Mississippi State University

Key Takeaways Jackson Center, PA, November 3, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Halberd Corporation (OTC: HALB), through its collaboration with scientists at Mississippi State University, continues work on a planned fourth quarter submission to the United States government seeking contractual funding for advanced animal research for the development

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.